CS Paper Radar

Deep Learning for Biopsy-Free Subtyping of Basal Cell Carcinoma from Dermatoscopic Images

Alexandros Papadopoulos, Chrysa Episkopou, Ioannis Sarafis, Aimilios Lallas, Anastasios Delopoulos

cs.CV cs.AI ·submitted 2026-09-07 08:13 UTC · v1

Abstract

Basal Cell Carcinoma (BCC) is the most common type of skin cancer, accounting for nearly 80% of skin cancer di- agnoses. Its optimal clinical management is guided by the distinct histopathologic subtype, with aggressive variants requiring more drastic measures. In current clinical practice, subtyping relies on skin biopsies, a procedure both costly and invasive. In this paper, we conduct a preliminary investigation into using deep learning for BCC subtyping, solely from a single dermatoscopic image of the lesion. Given the limited data at our disposal, we employ pre-trained vision transformers (ViTs), a state-of-the-art family of models highly effective for challenging downstream tasks with limited labeled data. Through repeated stratified k-fold cross-validation, we demonstrate that ViTs can achieve superior performance (AUC 0.784 on a dataset of 1271 dermatoscopic images of various BCC subtypes) over standard CNN-based baselines as well as previously-reported human reader perfor- mance, on the task of differentiating aggressive BCCs from other subtype families. These initial findings highlight the potential of combining deep learning and dermatoscopy to provide a biopsy- free alternative for BCC subtyping, thus aiding in improving treatment planning and patient outcomes.

Closest papers

Nearest neighbours by meaning across the whole index.

A Comparative Evaluation of Pre-trained Convolutional Neural Networks for Melanoma Detection

cs.CV cs.AI ·2026-09-10 ·Wagner Moreno Schmitz, Marco Antonio de Castro Barbosa, Thiago Magalhães Amaral, Dalcimar Casanova, Jefferson Tales Oliva
similarity 0.75
Abstract

Early diagnosis of melanoma is critical for improving patient survival rates. However, accurately distinguishing melanoma from other skin lesions remains a significant clinical challenge due to the high visual similarity among lesion types and variability in image acquisition conditions. Artificial intelligence, particularly machine learning, has emerged as a promising tool to support dermatological diagnosis by automating feature extraction from medical images. Among the available approaches, convolutional neural networks (CNNs) have demonstrated strong performance in image classification tasks, making them well-suited for analyzing both dermatoscopic and histopathological images, given their ability to capture hierarchical visual patterns relevant to lesion characterization. Nevertheless, despite numerous pre-trained CNN architectures having been proposed, selecting the most appropriate one for a given imaging modality remains an open challenge. In this study, we evaluate pre-trained convolutional neural networks (CNNs) for skin lesion classification using dermatoscopic and histopathological image datasets. Experiments were conducted on the HAM10000, ISIC 2018, and CR-AI4SkIN datasets, evaluating the ResNet50, VGG16, VGG19, MobileNet, and InceptionV3 architectures under the same training protocol. The experimental evaluation showed that the models achieved accuracies ranging from 71% (InceptionV3 on ISIC 2018) to 84% (ResNet50 on HAM10000) on dermatoscopic images. For histopathological images, accuracies ranged from 72% (VGG19) to 83% (ResNet50) on the CR-AI4SkIN dataset. The results demonstrate that model performance differs between dermatoscopic and histopathological image modalities, showing that architectures exhibiting similar performance on dermatoscopic images exhibit different performance on histopathological data.

0.16

CAMEO: A Class-Activation-Mapped Equitable Overlay Framework for Fair and Robust Deep Learning-based Skin Condition Diagnosis

eess.IV cs.CVcs.LG ·2026-09-28 ·Youssef Attia, Debasmita Mukherjee
similarity 0.74
Abstract · 21 pages, 9 figures

Deep learning classifiers for dermoscopic skin lesions often reach high in-distribution accuracy while quietly relying on spurious background cues such as skin tone, device vignetting, and embedded rulers, rather than on lesion morphology. This undermines robustness and fairness across skin tones. This work asks whether Explainable AI (XAI), typically used only to audit a finished model, can instead be repurposed as an active training signal that corrects this shortcut without sacrificing diagnostic accuracy. We introduce CAMEO (Class Activation Mapped Equitable Overlay), a framework that improves skin-lesion classification by selecting stable model explanations and using them to separate lesions from their backgrounds. It then replaces the background with realistic synthetic skin while keeping the lesion unchanged. On HAM10000 and dark-skin ISIC images, CAMEO maintained accuracy while reducing background-driven errors by nearly four times. It also made the model's attention more consistent when backgrounds changed. Results across multiple tests show that reducing reliance on background information improves robustness, with Fitzpatrick-based backgrounds providing a realistic and interpretable approach. Results show that XAI-guided augmentation can make dermoscopic classifiers measurably more robust and fair at no cost to accuracy. They also clarify that it is the mechanism and not the specific tone palette that matters, and that the lasting contribution of XAI here lies in stability-screened, annotation-free lesion localisation rather than in the robustness number itself.

0.12

Bridging Research and Practice: A Systematic Evaluation of Generalist and Dermatology-Specific Models in Clinical Skin Lesion Classification

cs.CV ·2026-10-02 ·Emanoel dos Santos, Kelvin Cunha, Rodrigo Mota, Fabio Papais, Thales Bezerra +6 more
top venuebenchmark similarity 0.72
Abstract · 10 pages, 1 figure, 3 tables, approved at MICCAI 2026

The application of machine learning to dermatology has grown substantially in recent years, moving beyond proof-of-concept studies toward potential applications. However, clinical dermatology remains a challenging and still open problem. Diagnostic assessment is often ambiguous, and skin lesions exhibit high variability, compounded by differences in acquisition modality, device quality, and patient demographics. These factors hinder the development of robust models suitable for safe and equitable clinical use. To support translation into practice, it is essential to systematically evaluate how contemporary models generalize across heterogeneous data sources. In this work, we benchmark a diverse set of architectures on recent dermatology datasets, spanning dermoscopic images and smartphone-based clinical photographs. We assess the robustness of recent general-purpose and medical vision-language models, as well as foundation models, and compare them against task-specific dermatology classifiers, including embedding-based approaches and convolutional neural networks. Our study provides an evaluation of model performance under distribution shifts, modality changes, and demographic variability. By quantifying the gap between current state-of-the-art models and the requirements of clinical deployment, we aim to contribute to the development of reliable, accessible, and clinically applicable AI systems for dermatology.

0.33

Uncertainty-Aware and Explainable Ensemble Deep Learning Framework for Multi-Class Skin Lesion Classification

eess.IV cs.AIcs.CVcs.LG ·2026-08-11 ·Rofiqul Islam, Lilatul Ferdouse
similarity 0.72
Abstract · 5 pages, 3 figures, IEEE AIBThings 2026

Skin cancer diagnosis from dermoscopic images remains challenging due to high intra-class variability, inter-class similarity, class imbalance, and the limited interpretability of deep learning models. This paper proposes an uncertainty-aware and explainable deep learning framework for multi-class skin lesion classification. The framework combines a vision transformer model (MaxViT-Tiny) with CNN-based models (ConvNeXt-Tiny and EfficientNetV2-B0) through deep ensemble learning. Monte Carlo (MC) Dropout estimates predictive uncertainty and identifies unreliable predictions, while Grad-CAM++, an explainable AI (XAI) technique, provides visual explanations by highlighting lesion regions that influence model decisions. Evaluated on the HAM10000 dataset, the framework achieves 96% accuracy and 99% ROC-AUC under uncertainty-aware filtering (entropy < 1.0, confidence >= 0.7), with macro-average precision, recall, and F1-score of 94%, 95%, and 95%, respectively, and 96% weighted-average scores across all three metrics. The results demonstrate accurate, interpretable, and uncertainty-aware skin lesion classification for trustworthy computer-aided diagnosis.

0.07

Contrastive Adapter Training and Consensus Knowledge Distillation for Multi-Source-Free Domain Adaptation in Skin Cancer Diagnosis

cs.CV cs.AI ·2026-11-02 ·Ali Abedi, Q. M. Jonathan Wu, Ning Zhang, Farhad Pourpanah
publishedcode/data similarity 0.71
Abstract · Published in Artificial Intelligence in Medicine, Vol. 180, 103465 (2026). DOI: https://doi.org/10.1016/j.artmed.2026.103465. Available at: …

Skin cancer diagnosis, particularly differentiating melanoma from benign nevi, is challenging due to the visual similarity between lesions. Although convolutional neural networks (CNNs) and vision transformers (ViTs) have shown promising performance, their effectiveness often deteriorates on data from heterogeneous clinical sources. Conventional domain adaptation methods address domain shift but require access to source data during adaptation, which is often infeasible due to privacy regulations. Multi-source-free unsupervised domain adaptation (MSFDA) addresses this limitation by leveraging multiple labeled source domains to generalize to an unlabeled target domain without requiring access to source data. However, existing MSFDA methods rely on full backbone fine-tuning, leading to catastrophic forgetting and overfitting on small clinical datasets, and address domain shift at the aggregation stage without establishing a shared domain-invariant feature space. Furthermore, their reliance on hard pseudo-labels or confidence-weighted aggregation introduces noisy supervision signals under domain shift. To address these limitations, we propose CAT-CKD, consisting of two components: (1) contrastive adapter training (CAT), which trains lightweight ConvPass adapters within a frozen ViT backbone using supervised contrastive learning (SCL) to establish a shared domain-invariant feature space before source-specific model training, and (2) consensus knowledge distillation (CKD), which aggregates logits from multiple source models into a consensus supervisory signal and adapts a student model on unlabeled target data using KL divergence. Experiments on five publicly available skin lesion datasets show that CAT-CKD achieves an average AUROC of 86.1%, outperforming existing MSFDA methods while requiring only 4.3M trainable parameters. The code is available at https://github.com/A-Abedi/CAT_CKD.

0.50

Deep Learning for Cervical Cytology Screening: Methods, Algorithms, Challenges and Prospects

cs.CV ·2026-11-01 ·Jiang Yangbo, Zheng Nenggan
benchmark similarity 0.70
Abstract

Cervical cancer remains a leading cause of cancer death among women, with more than 90\% of deaths occurring in low- and middle-income countries, where cytology screening is constrained by a shortage of trained cytopathologists. Deep learning has made automated cytology screening increasingly feasible, but the literature is fragmented across cell, patch and whole-slide-image scales, task formulations and supervision regimes, hindering comparison and clinical translation. This Review synthesizes the deep learning literature for cervical cytology screening, organizing the field along three axes---data scale, functional task and supervision---and distinguishing two clinical roadmaps: whole-slide-image confidence aggregation and cell-level detection with Bethesda classification. We examine 16 publicly available or publicly documented cytology datasets alongside the CAISHI histopathology dataset, compare quantitative performance while exposing incomparable metrics and data leakage, and assess commercial systems, regulatory status, HPV-era screening pathways and low-resource deployment. Single-cell accuracy on Herlev and SIPaKMeD has plateaued, but this reflects benchmark saturation rather than clinical readiness; prospective and randomized evidence is emerging but remains limited. We consolidate the evidence into five challenge areas---data and benchmarks, architecture and label-efficient learning, trustworthy AI, clinical translation and health economics, and evaluation and reproducibility---and provide an evidence-to-agenda map and a deployment decision matrix. Progress now depends on multi-center benchmarks, externally validated label-efficient methods, calibrated and fair predictions, and pragmatic clinical trials rather than further gains on saturated single-cell benchmarks.

0.09

A Lightweight Attention-Based CNN with Saliency-Map Interpretability for Skin Cancer Detection

cs.CV cs.AI ·2026-10-27 ·Sanjana Islam Kasfia, Md. Ismiel Hossen Abir, AKM Bahalul Haque, Abir Mahmud Shahariar
similarity 0.69
Abstract

Skin cancer is among the most prevalent and life threatening forms of cancer worldwide. Early and accurate diagnosis significantly improves patient survival rates. However, manual dermoscopic assessment remains challenging due to visual similarity. This study proposes an Explainable AI-driven framework for automated binary classification of skin lesions using a lightweight attention-based convolutional neural network (CNN-Attention). The model integrates channel attention to focus on informative regions of dermoscopic images while maintaining low computational complexity. A publicly available dataset comprising 2,637 training and 660 test images was used, with balanced class weights. The proposed model achieved 87 percent accuracy with 1.95 million parameters and 7.45 MB of storage, matching the best baseline (MobileNet) while using approximately half as many parameters and half as much storage. ROC AUC and PR AUC scores reached 0.9475 and 0.9430, respectively. Additionally, saliency maps were incorporated as an explainability technique to visualize regions that influence model decisions. Comparative analysis with VGG16,VGG19,ResNet101,and MobileNet demonstrates the proposed models effectiveness in balancing classification results, computational efficiency, and interpretability.

0.09

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

cs.CV cs.AI ·2026-08-16 ·Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
benchmark similarity 0.69
Abstract · 8 pages

Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination. Although deep learning has shown considerable potential in computational pathology, comprehensive benchmarks that integrate tissue classification and region segmentation within a unified analytical framework remain limited. This study presents a two-stage deep learning framework for multi-class tissue classification and pixel-level histopathological region segmentation, accompanied by a systematic comparison of state-of-the-art architectures at each stage. For tissue classification, six models, a custom convolutional neural network, VGG16, DenseNet, MobileNetV3, a custom Vision Transformer, and YOLO11, are evaluated on a combined dataset of 39,000 images derived from LC25000 and LungHist700. The models distinguish between adenocarcinoma, squamous cell carcinoma, and normal lung tissue. YOLO11 achieves the best classification performance, with an accuracy of 98.38%, a five-fold cross-validation accuracy of 98.21 +/- 0.35%, and a macro F1-score of 0.98. For region segmentation, U-Net, ResNet-encoder U-Net, DeepLabV3+, and YOLO11-seg are evaluated using the GlaS gland segmentation benchmark. DeepLabV3+ obtains the highest Intersection over Union of 0.80 and a Dice score of 0.89, while YOLO11-seg achieves a comparable Intersection over Union of 0.79 using approximately 14x fewer parameters. The best-performing classification and segmentation models are subsequently integrated into an end-to-end framework, providing an accurate, computationally efficient, and reproducible baseline for automated histopathological image analysis.

0.40